AdaptHealth Corp. (NASDAQ:AHCO) Q4 2022 Earnings Call Transcript

Stephen Griggs: Correct.

Operator: . We’ll take our next question from Richard Close with Canaccord Genuity.

Unidentified Analyst: This is John Finney on for Richard Close. So we’ve been hearing from some of your competitors supply . So I was just kind of wondering what is the state of your backlog today? And what do you see — do you still see that being bled down probably by in the first half of 2023. And do you still see yourself gaining market share through bleeding down faster than competitors?

Stephen Griggs: Yes, we had stated that our backlog, we should be through it by the end of the first quarter, first part of the second quarter. I think we’re on pace for that. So we will see that. And we do believe, based on the amount of new patients that we’re getting that our market share has improved from pre-pandemic or pre-recall levels. So we’re pretty confident and we’re not pretty — we’re very confident that those will continue, and so we’re in good shape.

Operator: And it appears that we have no further questions at this time. I will now turn the program back over to our presenters for any additional or closing remarks.

Stephen Griggs: We’d just like to thank everybody for attending. We appreciate the support, and we look forward to working hard in ’23 and managing our costs better and continue to deliver the revenues that we have. Thank you very much, and we appreciate everybody.

Operator: That concludes today’s teleconference. Thank you for your participation. You may now disconnect.